We are unable to draw overwhelming conclusions regarding these hormonal alterations as a result of the methodological problems with measuring androgens in PCOS, the limited sample size, and the absence of any direct evidence on the effects of beinaglutide on SHBG secretion. Here, SHBG is linked to polycystic ovary syndrome.